Related references
Note: Only part of the references are listed.Homologous and Heterologous Covid-19 Booster Vaccinations
R. L. Atmar et al.
NEW ENGLAND JOURNAL OF MEDICINE (2022)
Covid-19 Vaccine Effectiveness in New York State
Eli S. Rosenberg et al.
NEW ENGLAND JOURNAL OF MEDICINE (2022)
Association between reactogenicity and SARS-CoV-2 antibodies after the second dose of the BNT162b2 COVID-19 vaccine
Shohei Yamamoto et al.
VACCINE (2022)
Young age, female sex, and presence of systemic adverse reactions are associated with high post-vaccination antibody titer after two doses of BNT162b2 mRNA SARS-CoV-2 vaccination: An observational study of 646 Japanese healthcare workers and university staff
Yoshifumi Uwamino et al.
VACCINE (2022)
Safety Monitoring of COVID-19 Vaccine Booster Doses Among Adults — United States, September 22, 2021–February 6, 2022
Anne M. Hause et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2022)
Adverse Effects and Antibody Titers in Response to the BNT162b2 mRNA COVID-19 Vaccine in a Prospective Study of Healthcare Workers
Si'Ana A. Coggins et al.
OPEN FORUM INFECTIOUS DISEASES (2022)
COVID-19 vaccine waning and effectiveness and side-effects of boosters: a prospective community study from the ZOE COVID Study
Cristina Menni et al.
LANCET INFECTIOUS DISEASES (2022)
Safety and Efficacy of a Third Dose of BNT162b2 Covid-19 Vaccine
Edson D. Moreira et al.
NEW ENGLAND JOURNAL OF MEDICINE (2022)
The association between adverse reactions and immune response against SARS-CoV-2 spike protein after vaccination with BNT162b2 among healthcare workers in a single healthcare system: a prospective observational cohort study
Daisuke Jubishi et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2022)
Higher Antibody Concentrations in U.S. Health Care Workers Associated with Greater Reactogenicity Post-Vaccination Jane
Jane A. Dickerson et al.
VACCINES (2022)
Fever after Vaccination against SARS-CoV-2 with mRNA-Based Vaccine Associated with Higher Antibody Levels during 6 Months Follow-Up
Andrea Kanizsai et al.
VACCINES (2022)
Surveillance of Safety of 3 Doses of COVID-19 mRNA Vaccination Using Electronic Health Records
Michiel J. M. Niesen et al.
JAMA NETWORK OPEN (2022)
Association of Reactogenicity with Immunogenicity of the ChAdOx1 nCoV-19 Vaccine in Patients Undergoing Hemodialysis
Ting-Yun Lin et al.
VACCINES (2022)
A highly specific and sensitive serological assay detects SARS-CoV-2 antibody levels in COVID-19 patients that correlate with neutralization
David Peterhoff et al.
INFECTION (2021)
Association between Reactogenicity and Immunogenicity after Vaccination with BNT162b2
Stilla Bauernfeind et al.
VACCINES (2021)
Spectrum Bias and Individual Strengths of SARS-CoV-2 Serological Tests-A Population-Based Evaluation
Sebastian Einhauser et al.
DIAGNOSTICS (2021)
SARS-CoV-2 Neutralization with BNT162b2 Vaccine Dose 3
Ann R. Falsey et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Does reactogenicity after a second injection of the BNT162b2 vaccine predict spike IgG antibody levels in healthy Japanese subjects?
Masaaki Takeuchi et al.
PLOS ONE (2021)
Can reactogenicity predict immunogenicity after COVID-19 vaccination?
Young Hoon Hwang et al.
KOREAN JOURNAL OF INTERNAL MEDICINE (2021)
Outbreak of SARS-CoV-2 Infections, Including COVID-19 Vaccine Breakthrough Infections, Associated with Large Public Gatherings — Barnstable County, Massachusetts, July 2021
Catherine M. Brown et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2021)
Occurrence of BNT162b2 Vaccine Adverse Reactions Is Associated with Enhanced SARS-CoV-2 IgG Antibody Response
Yoav Rechavi et al.
VACCINES (2021)
Dynamics of antibody response to BNT162b2 vaccine after six months: a longitudinal prospective study
Paul Naaber et al.
LANCET REGIONAL HEALTH-EUROPE (2021)
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
Markus Hoffmann et al.
CELL (2020)
The how's and what's of vaccine reactogenicity
Caroline Herve et al.
NPJ VACCINES (2019)
Sex differences in immune responses
Sabra L. Klein et al.
NATURE REVIEWS IMMUNOLOGY (2016)